| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.7M | +8.0% |
| R&D Expense | $72.5M | -1.1% |
| SG&A Expense | $29.4M | -7.6% |
| Operating Income | -$100.8M | +4.3% |
| Pre-tax Income | -$93.5M | +1.8% |
| Income Tax | -$8K | -100.7% |
| Net Income | -$93.4M | +3.2% |
| EPS (Basic) | -$0.51 | +5.6% |
| EPS (Diluted) | -$0.51 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.6M | -15.0% |
| Short-term Investments | $229.2M | +147.0% |
| Accounts Receivable | $2.2M | +54.7% |
| Current Assets | $267.4M | +113.5% |
| Total Assets | $455.1M | +1.5% |
| Current Liabilities | $16.8M | -15.9% |
| Total Liabilities | $38.9M | +2.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.4M | -14.9% |
| Capital Expenditures | $10.2M | -36.0% |
| Investing Cash Flow | -$19.9M | -131.0% |
| Financing Cash Flow | $89.5M | +1049.0% |
| Free Cash Flow | -$83.6M | -4.7% |
| +5.6% |
| Stockholders' Equity |
| $415.7M |
| +1.3% |